The Fortune Financial Undertakes Review of Stocks in the Healthcare and Services Sectors
November 27 2009 - 7:27AM
Marketwired
US markets declined but ended off their lows on Tuesday after the
Federal Reserve raised its forecast for 2010. Fed minutes indicated
that Federal Reserve officials are confident the US economic
recovery will be durable, but do not see employment or inflation
picking up soon. Today, we, at The Fortune Financial, have asked
some of the top analysts worldwide to give us their updated
feedback regarding the current market activity and position on US
Airways Group Inc. (NYSE: LCC), AMR Corporation (NYSE: AMR), Delta
Air Lines (NYSE: DAL), Amylin Pharmaceuticals Inc. (NASDAQ: AMLN),
Illumina Inc. (NASDAQ: ILMN) and Vertex Pharmaceuticals Inc.
(NASDAQ: VRTX). You can find these 6-pager reports by signing up on
The Fortune Financial. Just click on the link provided below:
http://www.thefortunefinancial.com/index.php?id=78
The following are extracts from today's analytical research
reports
-- LCC: We believe the company is doing an excellent job of managing
through this downturn
Is this a BUY, SELL or HOLD stock, click here to
find out.
-- AMR: Since October, the stock is on a bullish trend with
Is this a
BUY, SELL or HOLD stock, click here to
find out.
-- DAL: Since first week of September, the scrip has been correcting
itself and
Is this a BUY, SELL or HOLD stock, click here to
find out.
-- AMLN: The third quarter of fiscal 2009 was one of the strong
operational and financial results for the company which we believe was
Is
this a BUY, SELL or HOLD stock, click here to
find out.
-- ILMN: Stock is on a big run-up since second week of June
Is this a
BUY, SELL or HOLD stock, click here to
find out.
-- VRTX: Volumes still look strong on the stock and might bring in some
more corrections. Is this a BUY, SELL or HOLD stock, click here to
find out.
To have full access to these analyst opinions, sign up now at
The Fortune Financial.
About The Fortune Financial:
TheFortuneFinancial.com provides the highest level of
independent research and investment strategies with the sole
purpose of consistently identifying stocks that provide the biggest
return on investment for our subscribers.
TheFortuneFinancial.com is not affiliated or compensated by any
of the above mentioned companies, nor do we own a position in any
of the companies.
NYSE:AMR NYSE:DAL NASDAQ:AMLN NASDAQ:ILMN NASDAQ:VRTX NYSE:LCC
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Oct 2024 to Nov 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Nov 2023 to Nov 2024